CD BioGlyco's Glycoprotein Enrichment Platform: Enabling Reliable Detection from Challenging Biological Samples

Glycoproteins are pivotal in disease development, how the immune system reacts to pathogens and cellular communication. For this reason, they are particularly important targets for biomarker discovery and new therapies. However, scientists have historically faced substantial challenges in their analysis due to their scarcity, heterogeneous structural nature, and the complexity of their biological environment.

In response to this challenge, CD BioGlyco has developed a better platform for glycoprotein and glycopeptide purification from complex samples. This new technology is a step towards more specificity, clarity, and consistency for glycoprotein analysis. In developing this technology, a robust multi-lectin affinity glycoprotein enrichment protocol was created to yield optimal preparation for mass spectrometry.

Real-World Evidence Research Issue: Enrichment of Complex Samples
Rather than relying on sourcing solutions solely from research, the CD BioGlyco platform provides an all-inclusive solution specifically developed for true biological samples. Here are a few highlights from the many benefits to be had:
• This platform will work across a variety of sample types, including serum, various tissues, and cell contents, or even exosomes and extracellular vesicles.
• It enables enrichment of O- and N-glycoproteins, with custom multi-lectin mix options.
• It requires a very small sample size with proven confidence when detecting glycoproteins in trace amounts, significantly expanding the opportunities for biomarker risk determination.

The platform provides researchers with the ability to go beyond the typical barriers to detection to reach trustworthy and relevant insight into glycosylation sites.
Testing for these enriched or isolated samples involves careful consideration of technical aspects such as sample provenance and data confidence. CD BioGlyco likewise consider three major prescriptive scientific technical specifications:
CD BioGlyco outlines three primary elements that reinforce the platform:

Precision in Analysis: The system is compatible with state-of-the-art, high-resolution MS setups, ensuring glycosylation sites are pinpointed with assurance.

Streamlined Enrichment Process: Developed from years of refinement, this process enhances the accuracy and efficiency in complex sample setups.

Comprehensive Scientific Assistance: A collaborative team of glycobiologists and analytical experts are on hand to guide study planning, technique selection, and data analysis.

The robustness of the platform is grounded in the well-established principle of lectin-based enrichment. This approach, which leverages the specific binding of lectins to carbohydrate motifs, is recognized for its effectiveness in isolating glycoproteins from complex mixtures. This principle is particularly pivotal for studies involving small sample volumes, as it enhances the detection of low-abundance glycoproteins, making it highly relevant and applicable to this platform.

Applications Spanning Basic to Translational Research
The upgraded enrichment approach is versatile, suitable for:
· Uncovering biomarkers in cancer and related inflammatory conditions
· Analyzing glycosylation patterns in therapeutic antibodies
· Investigating mechanisms and integrating multi-omics data
· Quantifying changes in glycosylation patterns
Such versatile applications establish the platform as an essential resource for research institutions, clinical studies, and pharmaceutical innovations.

About CD BioGlyco

With a worldwide footprint, CD BioGlyco offers pioneering services in glycobiology analysis, ranging from glycoprotein enrichment and glycosylation-site mapping to site-specific quantification and analyzing glycosylation occupancy.
For further details, feel free to explore our Glycoprotein Enrichment service page.